BHVN Q3 2023 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$111M

Net Income

-$103M

EPS (Diluted)

$-1.50

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$95M

Free Cash Flow

-$96M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$383M

Total Liabilities

$93M

Stockholders' Equity

$290M

Cash & Equivalents

$112M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$111M	-$68M	-63.4%
Net Income	-$103M	-$69M	-49.0%